Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:271-277, doi:10.1016/S0735-1097(03)00626-0
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grande-Allen, K. J.
Right arrow Articles by Vesely, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grande-Allen, K. J.
Right arrow Articles by Vesely, I.

Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations

K. Jane Grande-Allen, PhD*, Brian P. Griffin, MD, FACC{dagger}, Norman B. Ratliff, MD{ddagger}, Delos M. Cosgrove, III, MD§ and Ivan Vesely, PhD*,*

* Biomedical Engineering, The Cleveland Clinic Foundation,, Cleveland, Ohio USA
{dagger} Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, Ohio USA
{ddagger} Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio USA
§ Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA



View larger version (91K):

[in a new window]
 
Figure 1 Hyaluronidase SD and chondroitinase ABC (HABC) and chondroitinase ACII (AC2) digests of leaflet and chordae, with the first lane showing monosaccharide/disaccharide standard (STD) bands. The 4S- and 6S-galNAc (N-acetylgalactosamine-4- and 6-sulfate) are the non-reducing terminal ends of the GAG chains. {Delta}Di0S = unsulfated chondroitin; {Delta}Di2S = chondroitin/dermatan 2-sulfate; {Delta}Di4S = chondroitin/dermatan-4-sulfate; {Delta}Di6S = chondroitin/dermatan-6-sulfate; {Delta}Di4,6S = chondroitin/dermatan-4,6-sulfate; {Delta}DiHA = hyaluronan.

 


View larger version (34K):

[in a new window]
 
Figure 2 Concentrations of individual glycosaminoglycan (GAG) classes. C-0-S = unsulfated chondroitin; C-4-S = chondroitin-4-sulfate; C-6-S = chondroitin-6-sulfate; D-4-S = dermatan-4-sulfate; D-6-S = dermatan-6-sulfate; HA = hyaluronan; XS = oversulfated chondroitin/dermatan sulfate. *p < 0.05, chordae versus leaflets; {dagger}p < 0.05, unileaflet prolapse (ULP) or bileaflet prolapse (BLP) versus normal.

 


View larger version (53K):

[in a new window]
 
Figure 3 Proportions of different glycosaminoglycan classes. C-0-S = unsulfated chondroitin; C-4-S = chondroitin-4-sulfate; C-6-S = chondroitin-6-sulfate; D-4-S = dermatan-4-sulfate; D-6-S = dermatan-6-sulfate; HA = hyaluronan; XS = oversulfated chondroitin/dermatan sulfate.*p < 0.05, unileaflet prolapse (ULP) or bileaflet prolapse (BLP) versus normal.

 


View larger version (33K):

[in a new window]
 
Figure 4 Lengths of chondroitin/dermatan sulfate chains. *p < 0.05, chordae versus leaflets; {dagger}p < 0.05, unileaflet prolapse (ULP) or bileaflet prolapse (BLP) versus normal; {ddagger}p < 0.05, ULP versus BLP. GAG = glycosaminoglycan.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement